For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Avedro, Inc.

USPTO Granted Patents = 54

% Expired Patents = 22.2

EPO Patents = 24

Forward Citations = 438

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Marc David Friedman (29 out of 43 patents)

David Muller (24 out of 50 patents)

Pavel Kamaev (16 out of 19 patents)

4. Mikhail Smirnov (14 out of 14 patents)

5. Desmond Christopher Adler (13 out of 42 patents)

6. David Usher (12 out of 26 patents)

7. Ronald Scharf (8 out of 8 patents)

8. Grace Elizabeth Lytle (6 out of 6 patents)

9. John Marshall (6 out of 22 patents)

10. Radha Pertaub (6 out of 6 patents)

11. Thomas Ryan (6 out of 6 patents)

12. Jun Zhang (5 out of 5 patents)

13. David C Iannetta (5 out of 5 patents)

14. Alexandra Nicklin (4 out of 4 patents)

15. Evan Sherr (4 out of 8 patents)

Core Competencies:

Corneal Ectatic Disorders

Cross-Linking Treatments

Photo-Crosslinker

Patient-Specific Treatment Patterns

Eye Tracking

Photosensitizer Activation

Bioresorbable Corneal Implants

Micro-Devices for Eye Treatment

Drug Delivery to Eye

Biomechanical Properties of Eye

Corneal Reshaping Techniques

Corneal Tissue Stabilization

54 patents: Sort by Forward Citations

1. 12697505 - Systems and methods for applying and monitoring eye therapy (2026-08-04),

2. 12673925 - Compounds and compositions for eye treatments (2026-07-07),

3. 12636185 - Systems and methods for treating an eye with a mask device (2026-05-26),

4. 12533021 - Systems and methods for determining cross-linking distribution in a cornea and/or structural characteristics of a cornea (2026-01-27),

5. 12453652 - Systems and methods treating for corneal ectatic disorders (2025-10-28),

6. 12427062 - Systems and methods for cross-linking treatments of an eye (2025-09-30),

7. 12420072 - Systems and methods for cross-linking treatments of an eye (2025-09-23),

8. 12344598 - Bis(diazirine) derivatives as photo-crosslinker for treating corneal ectatic disorders (2025-07-01),

9. 12311025 - Formulations for eye treatments (2025-05-27),

10. 12293513 - Systems and methods for generating patient-specific corneal cross-linking treatment patterns (2025-05-06),

11. 12171691 - Systems and methods for cross-linking treatments of an eye (2024-12-24),

12. 12144546 - Systems and methods for eye tracking during eye treatment (2024-11-19),

13. 12070618 - Systems and methods for photoactivating a photosensitizer applied to an eye (2024-08-27),

14. 12042433 - Systems and methods for eye tracking during eye treatment (2024-07-23),

15. 12016794 - Photoactivation systems and methods for corneal cross-linking treatments (2024-06-25),

Avedro, Inc. is a leading pharmaceutical and medical technology company. The company specializes in corneal remodeling and refractive surgery solutions. Avedro is dedicated to developing innovative products and therapies that address unmet needs in the ophthalmic community. Their groundbreaking technology includes non-invasive procedures for vision correction and treatments for keratoconus and other corneal diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

54 Patents

#31 in Waltham, MA

#371 in Massachusetts

#6,542 in US

#13,083 in the World

Waltham, MA, United States of America

Avedro, Inc.

Forward Citations = 438

40 inventors:

Marc David Friedman (29 out of 43 patents)

David Muller (24 out of 50 patents)

Pavel Kamaev (16 out of 19 patents)

4. Mikhail Smirnov (14 out of 14 patents)

5. Desmond Christopher Adler (13 out of 42 patents)

Please report any incorrect information to [email protected]

Loading…